Editas Medicine reported third-quarter 2026 results and a business update. The gene-editing company pointed to ongoing work in cardiovascular disease and in viv

BWB News TV • 2026-11-09 13:51 UTC • By Billy Odell Tucker-Robinson

Editas Medicine reported third-quarter 2026 results and a business update. The gene-editing company pointed to ongoing work in cardiovascular disease and in vivo research, alongside recent scientific presentations and investor outreach.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly